The association of testosterone and cognitive decline is inconclusive, and its joint effect with neurofilaments light chain (NfL) remains largely unknown.
A total of 581 non-demented older men in the Shanghai Aging Study were included. Blood total testosterone (TT), free testosterone (FT), and NfL were measured at baseline. The relationships between TT, FT, TT/FT-NfL, and cognitive decline were explored by Cox regression models.
During a median follow-up of 6.7 years, there was an inverse association between TT/FT and cognitive decline (TT, trend p = .004, Q1 vs Q4, hazard ratio [HR] = 4.39, 95% confidence interval [CI] = 1.60 to 12.04; FT, trend p = .002, Q1 vs Q4, HR = 5.29, 95% CI = 1.50 to 16.89). Compared to participants with high TT/FT-low NfL, those with low TT/FT-high NfL had significantly higher risks of cognitive decline (TT, HR = 5.10, 95% CI = 1.11 to 23.40; FT, HR = 6.14, 95% CI = 1.34 to 28.06).
Our findings suggest that the combination of testosterone and neurodegenerative markers may provide reliable predictive insights into future cognitive decline.

Testosterone is inversely associated with cognitive decline in older men.
There is a joint effect of testosterone and NfL on cognitive decline.
Sex hormone and neurodegeneration may synergistically contribute to cognitive deterioration.

If you do not see content above, kindly GO TO SOURCE.
Not all publishers encode content in a way that enables republishing at Neuro.vip.

This post is Copyright: Shuning Tang,
Zhenxu Xiao,
Fangting Lin,
Xiaoniu Liang,
Xiaoxi Ma,
Jie Wu,
Xiaowen Zhou,
Qianhua Zhao,
Junling Gao,
Qianyi Xiao,
Ding Ding | June 4, 2024

Wiley: Alzheimer’s & Dementia: Table of Contents